- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
InterMune | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
INTERMUNE INC
InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials.
|
|
| Symbol: |
ITMN |
| Exchange(s): |
Nasdaq Stock Market |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Dec 31, 2008
12 Months
us$
|
Dec 31, 2007
12 Months
us$
|
Dec 31, 2006
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000)
|
48,150
|
66,690
|
90,780
|
-24.19
|
|
Earnings before Interest & Tax ($000)
|
-92,150
|
-93,990
|
-104,420
|
N/A
|
|
Profit/Loss ($000)
|
-97,840
|
-94,590
|
-105,960
|
N/A
|
|
Earnings per Share
|
-2.51
|
-2.52
|
-3.08
|
N/A
|
|
Total Assets ($000)
|
172,220
|
262,440
|
257,580
|
-13.21
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity
|
125.50
|
253.57
|
2,669.99
|
|
|
Employees
|
N/A
|
N/A
|
N/A
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Dec 31, 2009,us$
|
12 Months ended
Dec 31, 2008,us$
|
%Change
|
|
Total Revenue ($000)
|
N/A
|
48,140
|
N/A
|
|
Profit/Loss ($000)
|
N/A
|
-97,740
|
N/A
|
|
Earnings per Share
|
N/A
|
-2.51
|
N/A
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares
|
46,670,000
|
39,330,000
|
|
|
|
|
|
COMPANY INFORMATION
|
| Key Personnel |
| CEO: William R. Ringo Jr., Chmn. |
| CFO: Daniel G. Welch, Presi.; C.E.O.; Dir. |
| |
| Contact Information |
| Address: |
3280 Bayshore Boulevard,
Brisbane,
CA,
94005 |
Phone: |
415-466-2200 |
| Fax: |
415-466-2300 |
| Web Address: |
www.intermune.com |
| E-Mail : |
ir@intermune.com |
| |
| Incorporation:
| United States |
| |
|
Securities:
|
ITMN-Q
|
|
| |
|
|
| |
|
|
Financial data is provided by Zacks Investment Research.
| |
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
